In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration.
Journal
Human genetics
ISSN: 1432-1203
Titre abrégé: Hum Genet
Pays: Germany
ID NLM: 7613873
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
21
12
2020
accepted:
27
03
2021
pubmed:
10
4
2021
medline:
31
10
2021
entrez:
9
4
2021
Statut:
ppublish
Résumé
We investigated the clinical, genetic, and pathological characteristics of a previously unknown severe juvenile brain disorder in several litters of Parson Russel Terriers. The disease started with epileptic seizures at 6-12 weeks of age and progressed rapidly to status epilepticus and death or euthanasia. Histopathological changes at autopsy were restricted to the brain. There was severe acute neuronal degeneration and necrosis diffusely affecting the grey matter throughout the brain with extensive intraneuronal mitochondrial crowding and accumulation of amyloid-β (Aβ). Combined homozygosity mapping and genome sequencing revealed an in-frame 6-bp deletion in the nuclear-encoded pitrilysin metallopeptidase 1 (PITRM1) encoding for a mitochondrial protease involved in mitochondrial targeting sequence processing and degradation. The 6-bp deletion results in the loss of two amino acid residues in the N-terminal part of PITRM1, potentially affecting protein folding and function. Assessment of the mitochondrial function in the affected brain tissue showed a significant deficiency in respiratory chain function. The functional consequences of the mutation were modeled in yeast and showed impaired growth in permissive conditions and an impaired respiration capacity. Loss-of-function variants in human PITRM1 result in a childhood-onset progressive amyloidotic neurological syndrome characterized by spinocerebellar ataxia with behavioral, psychiatric and cognitive abnormalities. Homozygous Pitrm1-knockout mice are embryonic lethal, while heterozygotes show a progressive, neurodegenerative phenotype characterized by impairment in motor coordination and Aβ deposits. Our study describes a novel early-onset PITRM1-related neurodegenerative canine brain disorder with mitochondrial dysfunction, Aβ accumulation, and lethal epilepsy. The findings highlight the essential role of PITRM1 in neuronal survival and strengthen the connection between mitochondrial dysfunction and neurodegeneration.
Identifiants
pubmed: 33835239
doi: 10.1007/s00439-021-02279-y
pii: 10.1007/s00439-021-02279-y
pmc: PMC8519929
doi:
Substances chimiques
Amyloid beta-Peptides
0
Metalloendopeptidases
EC 3.4.24.-
pitrilysin
EC 3.4.24.55
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1593-1609Subventions
Organisme : Italian Ministry of Education
ID : MIUR, 2018-2022
Informations de copyright
© 2021. The Author(s).
Références
Bioinformatics. 2012 Sep 15;28(18):i333-i339
pubmed: 22962449
J Biol Chem. 2006 Sep 29;281(39):29096-104
pubmed: 16849325
Bioinformatics. 2015 Aug 15;31(16):2745-7
pubmed: 25851949
Structure. 2014 Jul 8;22(7):996-1007
pubmed: 24931469
J Mol Biol. 2011 Jul 15;410(3):400-10
pubmed: 21621546
Brain. 2013 Aug;136(Pt 8):2393-404
pubmed: 23625061
J Vet Intern Med. 2014 Jul-Aug;28(4):1186-98
pubmed: 24962505
Sci Rep. 2015 Aug 03;5:12810
pubmed: 26235384
PLoS One. 2012;7(10):e46688
pubmed: 23056405
J Med Genet. 2014 Mar;51(3):170-5
pubmed: 24367056
Front Genet. 2020 Mar 03;11:152
pubmed: 32194629
BMC Vet Res. 2015 Aug 28;11:182
pubmed: 26316133
Nat Methods. 2015 Oct;12(10):966-8
pubmed: 26258291
J Alzheimers Dis. 2011;27(1):75-87
pubmed: 21750375
Nat Genet. 2004 May;36(5):449-51
pubmed: 15064763
Mol Psychiatry. 2020 Jul 7;:
pubmed: 32632204
EMBO Mol Med. 2015 Dec 23;8(3):176-90
pubmed: 26697887
Genome Res. 2017 Nov;27(11):1916-1929
pubmed: 28855259
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Cytogenet Genome Res. 2005;110(1-4):462-7
pubmed: 16093699
Methods Mol Biol. 2014;1205:1-12
pubmed: 25213235
Hum Genet. 2019 May;138(5):525-533
pubmed: 30877375
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
J Pharmacol Exp Ther. 2012 Sep;342(3):619-30
pubmed: 22700435
Brain. 2012 Dec;135(Pt 12):3627-34
pubmed: 23065482
J Med Genet. 2018 Sep;55(9):599-606
pubmed: 29764912